In addition, in hepatocellular carcinoma cells, Dynasore, but not Dyngo-4a, was shown to affect the cell cycle distribution [31], which points to cell type-dependent effects of at least some of the dynamin inhibitors. This evidence concerns the gene DNM1 and hepatocellular carcinoma.